Celon Pharma SA banner
C

Celon Pharma SA
WSE:CLN

Watchlist Manager
Celon Pharma SA
WSE:CLN
Watchlist
Price: 19.92 PLN 0.61% Market Closed
Market Cap: zł1.1B

Wall St Price Targets

CLN Price Forecast
Based on 4 analysts

-8% Downside
from zł19.92 today

CLN Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for CLN yet.

Celon Pharma SA Competitors:
Price Targets

Revenue
Forecast

7% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
7% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 13%.

Gross Profit
Forecast

6% / Year
Past Growth
-16% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
-16% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is -16%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
22%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
22%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CLN's stock price target?
Price Target
18.36 PLN

According to Wall Street analysts, the average 1-year price target for CLN is 18.36 PLN with a low forecast of 16.16 PLN and a high forecast of 22.79 PLN.

What is the Revenue forecast for Celon Pharma SA?
Projected CAGR
13%

Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 13%.

What is the Gross Profit forecast for Celon Pharma SA?
Projected CAGR
-16%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is -16%.

Back to Top